Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of two dydrogesterone regimens for menorrhagia
ChiCTR2600134570Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dydrogesterone in hypermenorrhea and menstrual disorders (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Change in menstrual blood loss and Hemostatic effect. Planned start May 2026; status: not yet recruiting.
02
Drugs
dydrogesterone
03
Conditions
hypermenorrheamenstrual disorders
Beyond the preview
Go deeper on ChiCTR2600134570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134570.